US Patent Issued to Celex Oncology Innovations on May 12 for "Monoclonal antibodies against neonatal Na v 1.5" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,101, issued on May 12, was assigned to Celex Oncology Innovations Ltd. (London).

"Monoclonal antibodies against neonatal Na v 1.5" was invented by Mustafa Bilgin Ali Djamgoz (London) and Carsten Faltum (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Describe herein are binding molecules which specifically bind to neonatal 5'-exon splice variants of the a subunit of Nav1.5 (nNav1.5), including monoclonal antibodies and antigen-binding fragments, bispecific antibodies and antibody-drug conjugates derived from such monoclonal antibodies, and NK and T cells comprising chimeric antigen receptors derived from such monoclonal antibodies, and their us...